CWICX
Price
$75.55
Change
-$0.29 (-0.38%)
Updated
Oct 9 closing price
Net Assets
142.77B
LGCRX
Price
$19.79
Change
-$0.05 (-0.25%)
Updated
Oct 9 closing price
Net Assets
318.86M
Interact to see
Advertisement

CWICX vs LGCRX

Header iconCWICX vs LGCRX Comparison
Open Charts CWICX vs LGCRXBanner chart's image
American Funds Capital World Gr&Inc 529C
Price$75.55
Change-$0.29 (-0.38%)
VolumeN/A
Net Assets142.77B
Lord Abbett Global Equity R3
Price$19.79
Change-$0.05 (-0.25%)
VolumeN/A
Net Assets318.86M
CWICX vs LGCRX Comparison Chart in %
View a ticker or compare two or three
VS
CWICX vs. LGCRX commentary
Oct 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWICX is a Buy and LGCRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWICX has more cash in the bank: 143B vs. LGCRX (319M). CWICX pays higher dividends than LGCRX: CWICX (0.71) vs LGCRX (0.14). CWICX was incepted earlier than LGCRX: CWICX (24 years) vs LGCRX (9 years). LGCRX (1.97) is less costly to investors than CWICX (1.53). LGCRX is a more actively managed with annual turnover of: 41.00 vs. CWICX (27.00). LGCRX has a lower initial minimum investment than CWICX: LGCRX (0) vs CWICX (250). LGCRX annual gain was more profitable for investors over the last year : 18.92 vs. CWICX (11.05). LGCRX return over 5 years is better than : 52.85 vs. CWICX (48.82).
CWICXLGCRXCWICX / LGCRX
Total Expense Ratio1.531.15133%
Annual Report Gross Expense Ratio1.531.9778%
Fund Existence24 years9 years-
Gain YTD20.24020.097101%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets143B319M44,828%
Annual Yield % from dividends0.710.14517%
Returns for 1 year11.0518.9258%
Returns for 3 years68.0984.6280%
Returns for 5 years48.8252.8592%
Returns for 10 years87.02N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LCTX1.750.02
+1.16%
Lineage Cell Therapeutics
MKSI134.261.29
+0.97%
MKS Inc
LANDP19.30-0.05
-0.26%
Gladstone Land Corp
SEM13.64-0.60
-4.21%
SELECT MEDICAL HOLDINGS Corp
GPUS0.53-0.04
-7.02%
Hyperscale Data Inc